President Trump Announces Deal with AstraZeneca on Drug Prices and Tariffs

President Trump announces deal with AstraZeneca on drug prices and tariffs

Bringing Taiwan to the World and the World to Taiwan

AstraZeneca (and others) chooses Trump's United States

Following Pfizer, AstraZeneca has also reached an agreement with the Trump administration to avoid up to 100% tariffs. Meanwhile, however, it is cutting back on investment and research in the UK. Facts, figures, and comments Is US President Donald Trump's strategy toward the pharmaceutical sector bearing fruit? From his perspective, judging by the moves by Pfizer and AstraZeneca, it would appear so. The Anglo-Swedish pharmaceutical company, foll…

Astrazeneca bows to Donald Trump and slashes US drug prices by up to 80%

The Cambridge-based pharma giant said it will provide direct-to-consumer sales to eligible patients with prescriptions for chronic diseases at a discount of up to 80 per cent off list prices

AstraZeneca inks Trump drug pricing deal amid tariff threats - Pharmaceutical Technology

The AstraZeneca-Trump MFN drug pricing deal allows Americans to access select branded medications for up to 80% less than list price.

AstraZeneca strikes deal with US to lower drug prices - UK Investor Magazine

AstraZeneca has announced an agreement with the Trump administration to dramatically reduce prescription medicine costs for American patients while preserving the country’s position as a global biopharmaceutical leader. The deal should draw a line under uncertainties about whether AstraZeneca will be hit by US tariffs, which could disrupt sales in its largest market. AstraZeneca shares […] The post AstraZeneca strikes deal with US to lower drug …

Astrazeneca vows to lower US medicine prices

Astrazeneca has bowed to pressure from US president Donald Trump to lower the cost of its medicines for patents in America. The Cambridge-based pharma giant said it will provide direct-to-consumer sales to eligible patients with prescriptions for chronic diseases at a discount of up to 80 per cent off list prices, alongside participating in the US government’s new direct purchasing platform, which will allow patients to purchase medicines at a r…